Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Surgery
    October 2025
  1. NIGAM A, Mederos MA, Aksoy YA, Alzumaili B, et al
    Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors.
    Surgery. 2025 Oct 9:109764. doi: 10.1016/j.surg.2025.109764.
    >> Share

  2. OSORIO-SILLA I, Gonzalez DM, Quiceno Arias HD, Peinado PP, et al
    Differences in histopathologic features and diagnostic performance of (99m)Tc-methoxy-isobutyl-isonitrol single photon emission tomography-CT and (18)F-fluorocholine positron emission tomography-CT in primary hyperparathyroidism.
    Surgery. 2025;186:109595.
    >> Share

  3. MICALO L, Cho NY, Liu Z, Mallick S, et al
    Persistent racial disparities in the use of high-volume esophagectomy centers in the United States.
    Surgery. 2025;186:109554.
    >> Share

    September 2025
  4. MYLONAKIS A, Dimitrakoudi M, Vasilatou D, Tsapralis D, et al
    Primary esophageal lymphoma: An individual participant data meta-analysis.
    Surgery. 2025;185:109534.
    >> Share

    August 2025
  5. POLLMANN L, Weberskirch S, Petry M, Kubasch S, et al
    Indocyanine green quantification in full robotic esophagectomy using an unsupervised learning approach.
    Surgery. 2025;184:109405.
    >> Share

    July 2025
  6. VAGHAIWALLA TM, Henriksen EM, Chang J, Saghira C, et al
    Reassessing false-negative rate and size cutoff for papillary thyroid cancer with fine-needle aspiration in thyroid nodules.
    Surgery. 2025;186:109577.
    >> Share

  7. LINTIS A, Voron T, Passot G, Degisors S, et al
    Is preoperative smoking status a predictor of postoperative outcomes after esophagectomy for squamous cell carcinoma in a high-volume centre?
    Surgery. 2025;183:109379.
    >> Share

    May 2025
  8. SHAO K, Du Y, Xu L, Jiang Y, et al
    Outcomes of neoadjuvant immunochemotherapy and neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
    Surgery. 2025;183:109383.
    >> Share

  9. FORTMANN L, Hoelzen JP, Pascher A, Juratli MA, et al
    Amendment and subsumption of "Insights and comprehensive evaluation on 'Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer'".
    Surgery. 2025 May 2:109369. doi: 10.1016/j.surg.2025.109369.
    >> Share

  10. ZHAO Z, Huang W, Fu Y, Ji W, et al
    Comparative analysis of cis-cutting and retro-cutting techniques in gastric tube fabrication for preventing postoperative anastomotic leakage after esophagectomy.
    Surgery. 2025;181:109124.
    >> Share

    April 2025
  11. OHSAWA M, Hamai Y, Okada M
    Reply to letter to the editor titled "Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone".
    Surgery. 2025 Apr 25:109386. doi: 10.1016/j.surg.2025.109386.
    >> Share

  12. WEBER T, Smaxwil C, Hermann M, Lenschow C, et al
    Results of (18)F-choline and (11)C-methionine positron emission tomography/computed tomography for the preoperative localization of hyperfunctional parathyroid glands in primary hyperparathyroidism.
    Surgery. 2025;180:109056.
    >> Share

    March 2025
  13. YANG Y, Wang X, Kong Y
    Letter to the editor on "Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone".
    Surgery. 2025 Mar 17:109321. doi: 10.1016/j.surg.2025.109321.
    >> Share

    February 2025
  14. PAPINI P, Rossi L, Matrone A, De Renzis A, et al
    Prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma: 10-year impact on surgical and oncologic outcomes.
    Surgery. 2025;181:109258.
    >> Share

  15. NGO S, Hu TX, Zhu CY, Hughes EG, et al
    Utility of prophylactic central dissection in papillary thyroid carcinoma with clinically apparent lymph node metastases isolated to the lateral neck.
    Surgery. 2025;181:109160.
    >> Share

  16. AJAZ M
    Letter to the editor regarding "The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study".
    Surgery. 2025 Feb 6:109164. doi: 10.1016/j.surg.2025.109164.
    >> Share

    January 2025
  17. MORENO LLORENTE P, Alberich Prats M, Garcia Barrasa A, Pascua Sole M, et al
    Postoperative and permanent hypocalcemia after indocyanine green (ICG) angiography-guided total thyroidectomy and central neck dissection: A retrospective cohort study.
    Surgery. 2025;181:109142.
    >> Share

  18. LI K, Mao J, Yang X, Huang Y, et al
    Insights and comprehensive evaluation on "Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer".
    Surgery. 2025 Jan 22:109133. doi: 10.1016/j.surg.2024.109133.
    >> Share

    December 2024
  19. JI X, Liang W, Yu T, Ding C, et al
    Thyroid lobectomy for unilateral TNM T1 and T2 papillary thyroid carcinoma patients with lateral lymph node metastasis.
    Surgery. 2024;180:109028.
    >> Share

  20. PENNESTRI F, Procopio PF, De Crea C, Raffaelli M, et al
    Response letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 19:109001. doi: 10.1016/j.surg.2024.109001.
    >> Share

  21. WANG R, Liu X, Cai H, Li B, et al
    A nomogram to predict long-term survival after resection for esophageal cancer: An observational study in northeast China.
    Surgery. 2024;178:108968.
    >> Share

  22. VAGHAIWALLA TM, DeTrolio V, Saghira C, Akcin M, et al
    Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer.
    Surgery. 2024 Dec 16:108937. doi: 10.1016/j.surg.2024.
    >> Share

  23. MACHENS A, Dralle H
    Letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 6:108960. doi: 10.1016/j.surg.2024.108960.
    >> Share

    November 2024
  24. CHEREAU N, Gaujoux S, Ghander C, Bertocchio JP, et al
    Parathyroid hormone-based algorithm reduces complications after total thyroidectomy.
    Surgery. 2024 Nov 28:108933. doi: 10.1016/j.surg.2024.
    >> Share

    October 2024
  25. PRATT CG, Long SA, Whitrock JN, Holm TM, et al
    "Thanks, but no thanks": Factors associated with patients who decline surgical intervention for thyroid cancer.
    Surgery. 2024 Oct 30:S0039-6060(24)00837-7. doi: 10.1016/j.surg.2024.
    >> Share

  26. DICKERSON K, Milas M, Metzger R, Tomeh C, et al
    Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectability.
    Surgery. 2024 Oct 28:S0039-6060(24)00706-2. doi: 10.1016/j.surg.2024.
    >> Share

  27. RAMOS-FRESNEDO A, Phillips AL, Cantrell MC, Mobley EM, et al
    Cancer recurrence and survival among patients who underwent neoadjuvant treatment and surgery for esophageal cancer: A single-institution 10-year experience.
    Surgery. 2024 Oct 25:S0039-6060(24)00838-9. doi: 10.1016/j.surg.2024.
    >> Share

  28. CRAIG S, Stretch C, Yeo C, Fan J, et al
    Prognostication with Thyroid GuidePx in the context of tall cell variants.
    Surgery. 2024 Oct 25:S0039-6060(24)00810-9. doi: 10.1016/j.surg.2024.
    >> Share

  29. PROCOPIO PF, Pennestri F, Voloudakis N, La Rocca S, et al
    Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
    Surgery. 2024 Oct 24:S0039-6060(24)00809-2. doi: 10.1016/j.surg.2024.
    >> Share

  30. FUNG MHM, Luk Y, Lang BHH
    Early second radiofrequency ablation treatment gave rise to significantly greater nodule shrinkage at 12 months than single-session treatment for large-volume benign thyroid nodules.
    Surgery. 2024 Oct 24:S0039-6060(24)00807-9. doi: 10.1016/j.surg.2024.
    >> Share

  31. NOVIS E, Glover A, Grady JP, Silvestri A, et al
    Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program.
    Surgery. 2024 Oct 17:S0039-6060(24)00781-5. doi: 10.1016/j.surg.2024.
    >> Share

  32. OHSAWA M, Hamai Y, Emi M, Ibuki Y, et al
    Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone.
    Surgery. 2024 Oct 16:S0039-6060(24)00786-4. doi: 10.1016/j.surg.2024.
    >> Share

  33. CARNABATU CJ, Fetzer DT, Tessnow A, Holt S, et al
    Avoidable biopsies? Validating artificial intelligence-based decision support software in indeterminate thyroid nodules.
    Surgery. 2024 Oct 12:S0039-6060(24)00697-4. doi: 10.1016/j.surg.2024.
    >> Share

  34. TUMATI A, Marshall TE, Greenspun B, Chen Z, et al
    Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.
    Surgery. 2024 Oct 10:S0039-6060(24)00704-9. doi: 10.1016/j.surg.2024.
    >> Share

  35. ZHAO HH, Wilhelm SM
    Exploring ethnic diversity and clinical outcome variabilities in well-differentiated thyroid cancer among the Asian population.
    Surgery. 2024 Oct 8:S0039-6060(24)00698-6. doi: 10.1016/j.surg.2024.
    >> Share

  36. KURTOM S, Liu JB, Doerfler WR, Calcaterra M, et al
    Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence.
    Surgery. 2024 Oct 8:S0039-6060(24)00710-4. doi: 10.1016/j.surg.2024.
    >> Share

  37. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    Improvement in thyroid-specific quality of life following radiofrequency ablation of benign thyroid nodules: A USA study.
    Surgery. 2024 Oct 8:S0039-6060(24)00693-7. doi: 10.1016/j.surg.2024.
    >> Share

  38. ARTHURS L, Fredericks S, Attlassy Y, Raghunathan R, et al
    Language-based exclusion associations with racial and ethnic disparities in thyroid cancer clinical trials.
    Surgery. 2024 Oct 7:S0039-6060(24)00696-2. doi: 10.1016/j.surg.2024.
    >> Share

  39. JACOBS RC, Valukas CS, Visa MA, Logan CD, et al
    Association of operative time and approach on postoperative complications for esophagectomy.
    Surgery. 2024;176:1106-1114.
    >> Share

    September 2024
  40. BRAAFLADT S, Allison H, Chung J, Mariash CN, et al
    Dose-dependent relationship between levothyroxine and health-related quality of life in survivors of differentiated thyroid cancer.
    Surgery. 2024 Sep 27:S0039-6060(24)00647-0. doi: 10.1016/j.surg.2024.
    >> Share

  41. OH MY, Park D, Chai YJ, Kim K, et al
    Transoral robotic thyroidectomy: Lessons learned from consecutive series of 1,000 patients.
    Surgery. 2024 Sep 17:S0039-6060(24)00583-X. doi: 10.1016/j.surg.2024.
    >> Share

  42. YANG Y, Jiang C, Su Y, Pan J, et al
    Occurrence and recovery of vocal cord paralysis after minimally invasive McKeown esophagectomy, risk factors, and clinical outcome.
    Surgery. 2024;176:713-720.
    >> Share

    August 2024
  43. MACHENS A, Dralle H
    Response to letter to the editor on "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative, unifocal, nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Aug 30:S0039-6060(24)00222-8. doi: 10.1016/j.surg.2024.
    >> Share

  44. KIM LT
    Invited commentary on: YMSY-D-23-01181_R2. Overexpression of human DNA polymerase theta (POLQ) is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Aug 20:S0039-6060(24)00543-9. doi: 10.1016/j.surg.2024.
    >> Share

  45. JOGERST K, Zhang C, Chang YH, Gupta N, et al
    Dynamic volume-outcome association for esophagectomies: Do current volume thresholds still apply?
    Surgery. 2024;176:341-349.
    >> Share

  46. MATHIESEN MR, Piper TB, Olsen AA, Damtoft A, et al
    Textbook outcome after esophagectomy: A retrospective study from a high-volume center.
    Surgery. 2024;176:350-356.
    >> Share

    July 2024
  47. FEBRERO SANCHEZ B, Iborra E, Sanchez-Pedreno P, Ros-Madrid I, et al
    Analysis of the loss of phosphatase and tensin homolog expression in thyroid tissue for the diagnosis of Cowden syndrome.
    Surgery. 2024 Jul 6:S0039-6060(24)00384-2. doi: 10.1016/j.surg.2024.
    >> Share

  48. PALLEIKO BA, Dickson KM, Crawford A, Shafique S, et al
    Preoperative risk factors for anastomotic leak after esophagectomy with gastric reconstruction: A 6-year national surgical quality improvement (NSQIP) database analysis.
    Surgery. 2024;176:93-99.
    >> Share

  49. LEVENSON G, Coutrot M, Voron T, Gronnier C, et al
    Root cause analysis of mortality after esophagectomy for cancer: a multicenter cohort study from the FREGAT database.
    Surgery. 2024;176:82-92.
    >> Share

    June 2024
  50. HOELZEN JP, Fortmann L, Roy D, Szardenings C, et al
    Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience.
    Surgery. 2024 Jun 29:S0039-6060(24)00323-4. doi: 10.1016/j.surg.2024.
    >> Share

  51. KNIPPER K, Jung JO, Straatman J, Brunner S, et al
    The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study.
    Surgery. 2024 Jun 28:S0039-6060(24)00292-7. doi: 10.1016/j.surg.2024.
    >> Share

  52. JIANG KY, Zhang SX, Hu WL, Deng ZQ, et al
    Prognostic factors for patients with pathologic T1-T2N+ esophageal squamous cell carcinoma: A retrospective study with external validation.
    Surgery. 2024 Jun 19:S0039-6060(24)00326-X. doi: 10.1016/j.surg.2024.
    >> Share

  53. FRYE CC, Tennant L, Yeager A, Azimzadeh P, et al
    Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Jun 18:S0039-6060(24)00303-9. doi: 10.1016/j.surg.2024.
    >> Share

    May 2024
  54. XIAO X, Zhu Y, Li L, Liao Y, et al
    The effectiveness and safety of thermal ablation for thyroid carcinoma lymph node metastasis are affected by the diameter of metastatic lymph nodes: A meta-analysis.
    Surgery. 2024 May 21:S0039-6060(24)00233-2. doi: 10.1016/j.surg.2024.
    >> Share

  55. LUNARDI N, Jacob A, Elfenbein D, Schneider DF, et al
    Don't chase the adenoma: A probabilistic approach to imaging before parathyroidectomy.
    Surgery. 2024;175:1299-1304.
    >> Share

  56. MA S, Zhu J, Xue M, Shen Y, et al
    Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy: A large-volume retrospective study.
    Surgery. 2024;175:1305-1311.
    >> Share

    April 2024
  57. PAPAVRAMIDIS T, Chorti A, Cheva A
    Response to "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Apr 3:S0039-6060(24)00131-4. doi: 10.1016/j.surg.2024.
    >> Share

  58. CHALLINE A, Kirouani M, Markar SR, Tzedakis S, et al
    MIRO study: Do the results of a randomized controlled trial apply in a real population?
    Surgery. 2024;175:1055-1062.
    >> Share

    March 2024
  59. PIERCE K, Philips P, Egger ME, Scoggins CR, et al
    Developing sarcopenia during neoadjuvant therapy is associated with worse survival in esophageal adenocarcinoma patients.
    Surgery. 2024;175:718-725.
    >> Share

    February 2024
  60. DYAS AR, Mungo B, Bronsert MR, Stuart CM, et al
    National trends in technique use for esophagectomy: Does primary surgeon specialty matter?
    Surgery. 2024;175:353-359.
    >> Share

  61. DU J, Zeng T, Zhang S, Chen M, et al
    Comparison of indocyanine green-near-infrared fluorescence guided and traditional mediastinal lymphadenectomy during radical esophagectomy: A randomized controlled trial.
    Surgery. 2024;175:347-352.
    >> Share

  62. FUJITA T, Sato K, Fujiwara N, Kajiyama D, et al
    A novel imaging technology to assess tissue oxygen saturation and its correlation with indocyanine green in the gastric conduit during thoracic esophagectomy.
    Surgery. 2024;175:360-367.
    >> Share

    January 2024
  63. HEO DB, Won HR, Tae K, Kang YE, et al
    Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
    Surgery. 2024 Jan 27:S0039-6060(23)00967-4. doi: 10.1016/j.surg.2023.
    >> Share

  64. LUND S, Schmitz JJ, Foster T, Dy B, et al
    Ethanol ablation of papillary thyroid carcinoma nodal metastases: Long-term outcomes.
    Surgery. 2024 Jan 8:S0039-6060(23)00908-X. doi: 10.1016/j.surg.2023.
    >> Share

  65. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    >> Share

  66. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    >> Share

    December 2023
  67. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
    Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Surgery. 2023 Dec 22:S0039-6060(23)00887-5. doi: 10.1016/j.surg.2023.
    >> Share

  68. HU QL, Chen L, Kuo EJ, Lee JA, et al
    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.
    Surgery. 2023 Dec 13:S0039-6060(23)00871-1. doi: 10.1016/j.surg.2023.
    >> Share

  69. OWUSU-BRACKETT N, Chakedis JM, Dedhia P, Gilliam C, et al
    Efficacy and safety of near-infrared fluorescence identification of the thoracic duct during left lateral neck dissection.
    Surgery. 2023 Dec 5:S0039-6060(23)00683-9. doi: 10.1016/j.surg.2023.
    >> Share

    November 2023
  70. SZABO YAMASHITA T, Shirali AS, Meas S, Sarli V, et al
    Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?
    Surgery. 2023 Nov 21:S0039-6060(23)00636-0. doi: 10.1016/j.surg.2023.
    >> Share

  71. STURGEON C
    Addressing financial toxicity in thyroid cancer survivors in the United States.
    Surgery. 2023 Nov 10:S0039-6060(23)00755-9. doi: 10.1016/j.surg.2023.
    >> Share

  72. RUSSELL JO, Desai DD, Noel JE, Hussein M, et al
    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.
    Surgery. 2023 Nov 10:S0039-6060(23)00725-0. doi: 10.1016/j.surg.2023.
    >> Share

  73. SWANSON J, Roat-Shumway S, Cohn T, Luchette FA, et al
    Esophageal cancer: Does inaccuracy in clinical staging affect our ability to reach optimal outcomes?
    Surgery. 2023 Nov 4:S0039-6060(23)00518-4. doi: 10.1016/j.surg.2023.
    >> Share

  74. RAGHUNATHAN R, Longstaff XR, Hughes EG, Li SJ, et al
    Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hurthle cell cytology.
    Surgery. 2023 Nov 3:S0039-6060(23)00634-7. doi: 10.1016/j.surg.2023.
    >> Share

  75. LIN AC, Liu Z, Lee J, Ranvier GF, et al
    Generating a multimodal artificial intelligence model to differentiate benign and malignant follicular neoplasms of the thyroid: A proof-of-concept study.
    Surgery. 2023 Nov 2:S0039-6060(23)00635-9. doi: 10.1016/j.surg.2023.
    >> Share

    October 2023
  76. GIMBLET GR, Whitt J, Houson HA, Lin D, et al
    Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Surgery. 2023 Oct 31:S0039-6060(23)00631-1. doi: 10.1016/j.surg.2023.
    >> Share

  77. TUMATI A, Egan CE, Lee-Saxton YJ, Marshall TE, et al
    Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
    Surgery. 2023 Oct 29:S0039-6060(23)00626-8. doi: 10.1016/j.surg.2023.
    >> Share

  78. CARLISLE KM, Brown JP, Kim J, Turner DJ, et al
    Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
    Surgery. 2023 Oct 21:S0039-6060(23)00638-4. doi: 10.1016/j.surg.2023.
    >> Share

  79. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    The impact of social determinants of health on thyroid cancer mortality and time to treatment.
    Surgery. 2023 Oct 21:S0039-6060(23)00627-X. doi: 10.1016/j.surg.2023.
    >> Share

  80. HUSSEIN M, Toraih E, Issa PP, Omar M, et al
    From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation.
    Surgery. 2023 Oct 20:S0039-6060(23)00629-3. doi: 10.1016/j.surg.2023.
    >> Share

  81. ZHAO HH, Wilhelm SM
    Pediatric thyroid cancer: Socioeconomic disparities and their impact on access to care.
    Surgery. 2023 Oct 18:S0039-6060(23)00600-1. doi: 10.1016/j.surg.2023.
    >> Share

  82. DRALLE H, Brandenburg T, Weber F, Fuhrer-Sakel D, et al
    Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.
    Surgery. 2023 Oct 9:S0039-6060(23)00589-5. doi: 10.1016/j.surg.2023.
    >> Share

    September 2023
  83. VERM RA, Baker MM, Cohn T, Park S, et al
    Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer.
    Surgery. 2023 Sep 22:S0039-6060(23)00504-4. doi: 10.1016/j.surg.2023.
    >> Share

  84. AKGUN E, Romero-Velez G, Berber E
    Assessing the efficacy of thyroid nodule radiofrequency ablation using patient-reported outcome measures.
    Surgery. 2023 Sep 21:S0039-6060(23)00514-7. doi: 10.1016/j.surg.2023.
    >> Share

  85. SCHURING N, Donlon NE, Hagens ERC, Gootjes D, et al
    External validation of a nomogram predicting conditional survival after tri-modality treatment of esophageal cancer.
    Surgery. 2023 Sep 19:S0039-6060(23)00502-0. doi: 10.1016/j.surg.2023.
    >> Share

  86. TERANISHI R, Makino T, Tanaka K, Yamashita K, et al
    Corrigendum to "Long-term survival and prognostic factors associated with curative conversion surgery for cT4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases": Surgery. 2023 Sep;174(3):558-566. doi:10.1016/j.surg.2023.05.040.
    Surgery. 2023 Sep 5:S0039-6060(23)00528-7. doi: 10.1016/j.surg.2023.
    >> Share

    August 2023
  87. MONTGOMERY KB, Fazendin JM, Broman KK
    Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.
    Surgery. 2023 Aug 5:S0039-6060(23)00428-2. doi: 10.1016/j.surg.2023.
    >> Share

  88. LAYDI M, Doussot A, Lakkis Z, Mathieu P, et al
    Anatomic patterns of anastomotic leaks after Ivor Lewis esophagectomy for cancer: Impact on management and outcomes.
    Surgery. 2023;174:247-251.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016